Yoshizawa N, Kusumi Y, Matsumoto K, Oshima S, Takeuchi A, Kawamura O, Kubota T, Kondo S, Niwa H
Second Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Nephron. 1989;51(3):370-6. doi: 10.1159/000185325.
Peripheral blood mononuclear cells (PBMC) from patients with minimal-change nephrotic syndrome (MCNS) were tested for their ability to produce a factor which increases the urinary protein excretion levels of rats. It was shown that enhanced proteinuria can be produced in 8-hour urine specimens from rats by the injection of concentrated supernatants of cultured concanavalin-A-stimulated PBMC of patients with MCNS, but not from other nephrotics or normal subjects. The increase in urinary protein excretion was associated with a significant alteration of glomerular epithelial cells similar to that seen in MCNS. These results suggest that in MCNS, PBMC release a factor, which we termed a glomerular permeability factor (GPF), causing changes in glomerular permeability with resulting proteinuria.
对微小病变型肾病(MCNS)患者的外周血单个核细胞(PBMC)进行检测,以评估其产生一种能提高大鼠尿蛋白排泄水平的因子的能力。结果显示,给大鼠注射经刀豆蛋白A刺激培养的MCNS患者PBMC浓缩上清液后,大鼠8小时尿标本中可出现蛋白尿增强的情况,而其他肾病患者或正常受试者的PBMC浓缩上清液则不会导致这种情况。尿蛋白排泄增加与肾小球上皮细胞的显著改变有关,这与MCNS中所见的情况相似。这些结果表明,在MCNS中,PBMC释放一种我们称之为肾小球通透性因子(GPF)的因子,该因子会引起肾小球通透性改变,进而导致蛋白尿。